Indian Covid vaccine Covaxin granted EUA in Philippines

at 11:43 pm
Vaccine Price

New Delhi (NVI): In yet another milestone for India’s global vaccine outreach, Indian made Covid-19 vaccine- Covaxin has been granted Emergency Use Approval (EUA) in Philippines.

Apart from Covaxin, another corona vaccine- Janssen has also been granted EUA. FDA Director General Eric Domingo confirmed that Janssen Pharmaceuticals and Bharat Biotech have been granted permission for the emergency use of their vaccines in the Philippines.

India’s Ambassador to Philippines Shambhu Kumaran shared the news on Twitter. He also thanked Philippines Foreign Affairs Secretary Teodoro Locsin, Jr. and the Department of Health for their support to the vaccine.

“Delighted that #Covaxin has been granted EUA in the #Philippines. Congratulations @BharatBiotech!Thank you @FDAPhilippines. Appreciate support of @teddyboylocsin @DOHgovph and all friends of India in Philippines! Another decisive step in the long battle together against Covid-19!” he tweeted.

Covaxin is an Indian vaccine made by Bharat Biotech, headquartered in Hyderabad.

Janssen, the other vaccine approved by Philippines, is a single-dose vaccine developed by American drugmaker Johnson & Johnson which had applied for an EUA in Philippines on March 31.

Apart from that, last month, a Philippines team led by chief implementer of the Philippines’ Declared National Policy against COVID- Carlito Galvez Jr had visited India to finalise agreements with Serum Institute of India (SII) on supplies of Novovax vaccine.

The Philippines government had signed a deal in January to secure the supply of 30 million doses of the Covovax from Serum Institute of India (SII). The vaccine has been developed by US Pharma major Novovax and being manufactured in by Pune-based SII.

The Southeast Asian country has already given EUA approval to Pfizer-BioNTech, Oxford-AstraZeneca, Sinovac, and Gamaleya-Sputnik V vaccines.